Page last updated: 2024-11-06

cephaloridine and Prostatic Hyperplasia

cephaloridine has been researched along with Prostatic Hyperplasia in 1 studies

Cephaloridine: A cephalosporin antibiotic.
cefaloridine : A cephalosporin compound having pyridinium-1-ylmethyl and 2-thienylacetamido side-groups. A first-generation semisynthetic derivative of cephalosporin C.

Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Genster, HG1
Madsen, PO1

Other Studies

1 other study available for cephaloridine and Prostatic Hyperplasia

ArticleYear
Urinary tract infections following transurethral prostatectomy: with special reference to the use of antimicrobials.
    The Journal of urology, 1970, Volume: 104, Issue:1

    Topics: Aged; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteria; Bacteriuria; Ceph

1970